Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Propert

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
Single, sequential, and multiple alkylating agent therapy for multiple myeloma: a CALGB StudyM R Cooper, O R McIntyre, K J Propert, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 10, 2006
Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI)K J Propert, M S Litwin, Y Wang, et al.
Investigational New Drugs|May 1, 1990
Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B reportQ S Ringenberg, K J Propert, H B Muss, et al.
The New England Journal of Medicine|November 19, 1992
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVDG P Canellos, J R Anderson, K J Propert, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B studyM Coleman, S Rafla, K J Propert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group BV Vinciguerra, K J Propert, M Coleman, et al.
The New England Journal of Medicine|October 4, 1990
A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancerR O Dillman, S L Seagren, K J Propert, et al.
The Prostate|June 8, 2001
Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasiaS B Malkowicz, W G McKenna, D J Vaughn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group BA P Chahinian, K J Propert, J H Ware, et al.
The New England Journal of Medicine|April 9, 1987
Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lungM C Perry, W L Eaton, K J Propert, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
Single, sequential, and multiple alkylating agent therapy for multiple myeloma: a CALGB StudyM R Cooper, O R McIntyre, K J Propert, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|February 10, 2006
Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI)K J Propert, M S Litwin, Y Wang, et al.
Investigational New Drugs|May 1, 1990
Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B reportQ S Ringenberg, K J Propert, H B Muss, et al.
The New England Journal of Medicine|November 19, 1992
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVDG P Canellos, J R Anderson, K J Propert, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B studyM Coleman, S Rafla, K J Propert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group BV Vinciguerra, K J Propert, M Coleman, et al.
The New England Journal of Medicine|October 4, 1990
A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancerR O Dillman, S L Seagren, K J Propert, et al.
The Prostate|June 8, 2001
Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasiaS B Malkowicz, W G McKenna, D J Vaughn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group BA P Chahinian, K J Propert, J H Ware, et al.
The New England Journal of Medicine|April 9, 1987
Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lungM C Perry, W L Eaton, K J Propert, et al.
Pageof 6